Literature DB >> 2370577

Retinol, supplemental vitamin A and bone status.

M F Sowers1, R B Wallace.   

Abstract

Studies of hypervitaminosis A in animals and anecdotal reports of accidental vitamin A poisoning in humans suggest impairment of bone remodeling and increased numbers of fractures. Because of the widespread use of high-dose vitamin A supplements which may produce subclinical hypervitaminosis associated with decreased bone mass and increased risk of fracture, we studied the relationship between current vitamin A supplement use, serum retinol levels, radial bone mass and fracture history in a geographically-defined population of 246 postmenopausal women, 55-80 years of age. More than 36% of this population used a vitamin A supplement with 8% of these consuming an amount in excess of 2000 retinol equivalents (RE)/day. Serum retinol was measured using high-pressure liquid chromatography and radial bone mass was measured using single photon absorptiometry. After controlling for age, current estrogen replacement, and current thiazide antihypertensive use, we observed no statistically significant relationship between vitamin A supplement use or serum retinol with radial bone mass or fractures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2370577     DOI: 10.1016/0895-4356(90)90040-v

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.

Authors:  Kathleen E Bainbridge; MaryFran Sowers; Xihong Lin; Sioban D Harlow
Journal:  Osteoporos Int       Date:  2004-01-22       Impact factor: 4.507

Review 2.  Osteocytogenesis: Roles of Physicochemical Factors, Collagen Cleavage, and Exogenous Molecules.

Authors:  Xuening Chen; Lichen Wang; Kaitao Zhao; Hongjun Wang
Journal:  Tissue Eng Part B Rev       Date:  2018-01-05       Impact factor: 6.389

3.  Cortical and trabecular bone, bone mineral density, and resistance to ex vivo fracture are not altered in response to life-long vitamin A supplementation in aging rats.

Authors:  Amanda E Wray; Nori Okita; A Catharine Ross
Journal:  J Nutr       Date:  2011-02-10       Impact factor: 4.798

Review 4.  The role of morphogens in endochondral ossification.

Authors:  J T Campbell; F S Kaplan
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

5.  Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study.

Authors:  Graciela Caire-Juvera; Cheryl Ritenbaugh; Jean Wactawski-Wende; Linda G Snetselaar; Zhao Chen
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

6.  Vitamin A intake and the risk of hip fracture in postmenopausal women: the Iowa Women's Health Study.

Authors:  L S Lim; L J Harnack; D Lazovich; A R Folsom
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

7.  No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene.

Authors:  G L Ambrosini; A P Bremner; A Reid; D Mackerras; H Alfonso; N J Olsen; A W Musk; N H de Klerk
Journal:  Osteoporos Int       Date:  2012-09-18       Impact factor: 4.507

8.  No effect of vitamin A intake on bone mineral density and fracture risk in perimenopausal women.

Authors:  L Rejnmark; P Vestergaard; P Charles; A P Hermann; C Brot; P Eiken; L Mosekilde
Journal:  Osteoporos Int       Date:  2004-03-18       Impact factor: 4.507

Review 9.  Retinoid receptors in bone and their role in bone remodeling.

Authors:  Petra Henning; H Herschel Conaway; Ulf H Lerner
Journal:  Front Endocrinol (Lausanne)       Date:  2015-03-11       Impact factor: 5.555

10.  Clinically relevant doses of vitamin A decrease cortical bone mass in mice

Authors:  Vikte Lionikaite; Karin L Gustafsson; Anna Westerlund; Sara H Windahl; Antti Koskela; Juha Tuukkanen; Helena Johansson; Claes Ohlsson; H Herschel Conaway; Petra Henning; Ulf H Lerner
Journal:  J Endocrinol       Date:  2018-10-31       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.